Delivery Order SPE2DB20D1109-SPE2DB25FN92G
Award Date
4/18/25
Potential Completion Date
4/21/25
Potential Value
$2.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD), to Amerisourcebergen Drug Corp for the purchase of EMGALITY 300 MG (100 MG X3SYR)ML, a specialty pharmaceutical product. The contract has a firm fixed price of $4,236.32 and an ultimate completion date of May 9, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA,...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order valued at $1,081.90 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of EMGALITY 300 MG (100 MG X 3 SYR)ML, a pharmaceutical product, with a period of performance through May 10, 2024. This award is under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,416.08, is for the supply of EMGALITY 120 MG/ML PENML, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of April 1, 2025. There is no set-aside designation indicated for this award. Amerisourcebergen Drug Corp...
This is a Delivery Order contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,207.75, is for the supply of EMGALITY 120 MG/ML PENML, a pharmaceutical product, with a period of performance through February 10, 2025. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is valued at $4,200.44 and covers the procurement of EMGALITY 120 MG/ML PENML, a medication used for the treatment of various medical conditions. The contract has a completion date of December 14, 2023, and is a firm fixed-price delivery order with no set-aside requirements. Amerisourcebergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,296.75 firm fixed-price delivery order is for the supply of EMGALITY 120 MG/ML PENML, a pharmaceutical product. The contract has an ultimate completion date of April 7, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of EMGALITY 120 MG/ML PENML, a medication, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,108.36 and is a Firm Fixed Price Delivery Order that runs through January 8, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through...
This federal contract award is for the delivery of EMGALITY 120 MG/ML PENML, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, awarded to Amerisourcebergen Drug Corp, has a total ceiling value of $1,037.40 and a performance period through December 17, 2024. This delivery order contract is a firm-fixed-price arrangement, with no set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions...
This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,956.51, is for the delivery of EMGALITY 120 MG/ML PENML, a medical product. The contract has an ultimate completion date of September 20, 2023 and is a firm fixed-price agreement. This award is not designated as a set-aside contract. Amerisourcebergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,011.52 Firm Fixed Price Delivery Order contract is for the supply of EMGALITY 120 MG/ML PENML, a prescription medication. The contract has an ultimate completion date of September 25, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...